Pollock shares five takeaways from the Kittleson et al. guidance, which he says gives heart failure with preserved ejection fraction a real drug regimen.
Recap by typeshit. Post by Jeremy S. Pollock on X.
A professor walks through peptides as short amino acid chains and their roles in cell signaling and regulation.
A Mayo Clinic Florida study of over 3,800 women found 9.8% vs 8.2% weight loss at 9 months with HT on semaglutide. Researchers say it shows association, not cause.
Stanford doctors look at what peptides are and whether the online wellness hype holds up, covering possible upsides alongside the risks.
His GLP-1 series turns to heart failure with preserved ejection fraction, where the heart pumps normally but struggles to relax and fill.
A BusinessWorld piece on FDA worries about unapproved GLP-1 weight loss drugs, including retatrutide, which is still in trials. Few details were available.
Bloomberg reports the proposal now carries more patient safeguards than earlier versions. It could shape how peptides are sold and prescribed.
Loading…